This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A new anti-hangover supplement has just gone on sale in the UK. This means that if someone drinks 50 ml of 40 percent spirits, which contains […]. It is marketed by Swedish firm Myrkl as “the pre-drinking pill that works” The pill is said to break down up to 70 percent of alcohol after 60 minutes.
However, hopes the drug might reach a large swath of patients — and grow into a commercial blockbuster for its maker Mirati Therapeutics — have dimmed in the wake of underwhelming clinical trial results. The mutation is found in approximately 13% of lung tumors. Continue to STAT+ to read the full story…
This followed positive results from CSL’s Phase III HOPE-B trial (NCT03569891). Hemgenix works by dosing a patient with an engineered adeno-associated virus (AAV), containing the gene responsible for producing a protein called factor IX. Haemophilia B is a rare condition.
An investigational late-stage product candidate, CART-ddBCMA is being analysed in the Phase II iMMagine-1 clinical trial at present. It leverages the new D-Domain binder of Arcellx and contains autologous T cells genetically modified for targeting multiple myeloma. Additionally, Kite will make other potential payments to Arcellx.
Anti-inflammatory drugs like Restasis and Xiidra are popular treatment options for the condition, but will the emergence of mask-associated dry eye bolster their sales? But if you thought the growing number of patients presenting with mask-associated dry eye would mean higher sales for Restasis, think again.
Life sciences commercial organizations can now forecast sales, predict churn, analyze brand propensity and launch new products with BirdzAI . P360 , a leading developer of technology for life sciences companies, today announced major updates to its sales enablement platform BirdzAI. Partnering with P360 has allowed us to do just that.
The growing clinical trial market is increasing the need for efficient clinical dose contract manufacturing and marketing capabilities to achieve technical and commercial goals. The download contains detailed information on the providers and their services and solutions, alongside contact details to aid your purchasing or hiring decision.
According to GlobalData insight, gene therapies are expected to display the greatest forecasted sales growth, with an increase over 1,200%, while gene-modified cell therapies are expected to show the second greatest forecasted sales growth, with an increase slightly below 1,000%. Collaboration and integrated manufacturing.
Remarkable drop was observed in altered filamin A plasma levels after treatment with simufilam in Phase 2b trials. a biotechnology (clinical stage immuno-oncology) company from California publicized the design of its new XPro therapy in Phase 2 clinical trials. In 2019 as the uptake increased, Shingrix sales double folded.
One of the Johnson & Johnson’s top clinical trial readouts for 2023 just generated results, which bode very well for the future prospects of multiple myeloma CAR-T Carvykti. The post Trial sets up earlier use of J&J’s Carvykti in myeloma appeared first on. BMS is due to report fourth quarter results on 2 February.
In the ASCEMBL trial , Scemblix achieved a major molecular response (MMR) at 24 weeks in 25% of patients in Ph+ CML in the chronic phase – when the blood and bone marrow contains less than 10% malignant cells – which compared to a 13% MMR with Pfizer’s Bosulif (bosutinib). Tasigna made sales of $1.56
The top 15 diabetes drugs in 2023, according to 2022 sales data, reflect the current state of diabetes management and hint at the evolving needs and trends within this critical area of healthcare. Read on to learn more about the top 15 diabetes drugs in 2023, based on 2022 sales statistics. mL subcutaneous solution (2 mg/1.5
… A Delaware federal court refused to throw out patent infringement claims brought by Arbutus Biopharma and Genevant Sciences against Moderna over its sale of Covid-19 vaccine doses to the U.S. Genevant and Arbutus sued Moderna in February, seeking royalties from Moderna’s sale of its Covid-19 vaccine.
Presumably, Antares’ long-established 90-person urology sales force can achieve pull-thru of this drug product. In October, Antares Pharma licensed Ferring Pharmaceuticals’ Nocdurna® (desmopressin acetate) sublingual tablet , which was approved in 2018 for the same indication as Noctiva and has a boxed warning highlighting the same risks.
Moderna’s new version of its COVID-19 vaccine, which targets two virus variants including Omicron, has outperformed the company’s original Spikevax shot in a head-to-head clinical trial. It has predicted sales of COVID-19 vaccines will be around $21 billion this year.
Without a doubt, codeine-containing products are one of the most commonly sold medicines in the UK. Restrictions on the supply of codeine-containing products. The main focus of this post is to introduce the most common over the counter codeine-containing products in the UK and review their codeine content.
Celevac is a brand of tablets containing methylcellulose. Each Celevac tablet contained 500mg of methylcellulose. Celevac tablets were licensed as general sale list medicines (GSL), which means they could be sold in any retail outlet, including pharmacies, over the counter without a prescription. . What is Celevac?
Zovirax cream, marketed as Zovirax Cold Sore Cream, contains 5% of aciclovir. Zovirax over the counter availability Zovirax Cold Sore Cream is licensed as general sale list medications (GSL). Patients were randomly given either Zovirax cream (containing aciclovir) or a placebo cream, which did not have any active ingredients.
The FDA’s complete response letter (CRL) did not take issue with the efficacy or safety of lenacapavir but focused on chemistry, manufacturing and controls (CMC) data, specifically relating to the proposed container vial and its compatibility with the active drug.
The Government recently announced the reclassification of fexofenadine 120mg, which will be available as General sale Medication (GSL), sold as branded products – Allevia 120mg tablets. People who take indigestion remedies, which contain aluminium or magnesium should leave 2 hours between taking Allevia tablets.
Both products contain the same active ingredients regardless of whether they are prescribed or purchased over the counter: Each Buscopan tablets contains 10mg of hyoscine butylbromide. Each Colofac or mebeverine tablet contains 135mg of mebeverine hydrochloride. Both products contain the same drug – hyoscine butylbromide.
Lilly is also working towards an obesity treatment form of tirzepatide, with trials currently underway to evaluate its weight loss effects. Since Mounjaro’s May US Food and Drug Administration (FDA) approval, sales of the drug have skyrocketed beyond initial expectations owing to patient demand and a temporary shortage of Novo’s Ozempic.
billion for its FDA-approved dry eye drug Xiidra during the Japanese pharma’s merger with Shire in 2019, outlining the sales potential in this market niche. Sylentis, part of PharmaMar Group, has just announced FDA approval of a phase 3 trial for eye drops containing tivanisiran, in dry eye disease associated with Sjogren’s Syndrome.
Sale of some anti-itch creams is restricted to pharmacies only. Lotions: contain the least amount of oils and higher amounts of water with non-greasy consistency. It contains a combination of miconazole (an antifungal drug) and hydrocortisone 1% (steroid). Ointments, creams and lotions can be used as soap substitutes.
BOSTON–( BUSINESS WIRE )– AVEO Oncology (Nasdaq: AVEO) today announced the appointment of David Crist as Vice President of Sales. Mr. Crist brings more than twenty years of oncology sales experience in both launch-stage and late-stage companies, building commercial organizations and developing high performing sales force teams.
Airsupra is a pressurized fixed-dose combination rescue medication inhaler containing a beta-2 adrenergic agonist (albuterol) and a corticosteroid (budesonide). It’s the first medication that contains an anti-inflammatory inhaled corticosteroid (ICS) and a short-acting beta-agonist to be approved in the US.
While some newer plastics are made from recycled food or plant materials, most are made from petroleum and contain polymers and other additives. Manufacturing packaging often pollutes the air with greenhouse gases, heavy metals and particulates and produces wastewater that contains potentially toxic contaminants.
ChAdOx1 – which is in large-scale phase 2/3 trials – was licensed by AZ in April and renamed AZD1222, and should be ready for first deliveries before the end of the year. It will be provided on a no-profit basis while the pandemic is ongoing. Those deals cover 200 million doses of J&J’s Ad26.COV2.S
Amorolfine 5% nail lacquer (brand name: Curanail 5% w/v Medicated Nail Lacquer) is available as general-sale medication, which can be purchased in most supermarkets and pharmacies. Curanail Once Weekly 5% Fungal Nail Treatment Curanail Once Weekly Fungal Nail treatment contains 5% of amorolfine hydrochloride as an active ingredient.
That means it targets both the primary mutation in this form of NSCLC and the resistance mechanism at the same time, according to J&J, which has previously said it plans to expand use of the drug to “all EGFR-containing tumours”, challenging Tagrisso and other TKIs like AZ’s older Iressa (gefitinib) and Roche’s Tarceva (erlotinib).
The treatment is based on the Grifols immunoglobulin Gamunex®-C, and contains anti-SARS-COV-2 polyclonal antibodies from plasma donors who have recovered from COVID-19.
It could also help contain outbreaks in places where the vaccination hasn’t begun or is still underway.
BARCELONA, Spain , Jan. and on the U.S.
The CSP Guidance was revised to reflect amendments to the definition of “authorization for sale” in the Certificate of Supplementary Protection Regulations ( CSP Regulations ) and to reflect changes to Health Canada’s administrative practices. Health Canada has also updated its fee for CSP applications.
Epidiolex contains sesame seed oil, restricting its use for some individuals. PureTech’s other CBD pill candidate, LYT-300 (oral allopregnanolone), is currently being evaluated in a multi-part Phase I trial evaluating its oral bioavailability, safety and tolerability and optimal dosing. billion deal in 2021.
Johnson’s Baby Powder also went on sale during this year and was extremely successful. But like many of its big pharma peers, it faces increased pressure on some of its biggest brands, as expiring patents pave the way for generic competition while biosimilars undercut sales of biologics.
Most of the company’s revenue comes from the manufacture and sale of biopharmaceutical products. It contains the antiviral medications nirmatrelvir and ritonavir. billion in pharmaceutical sales from 2021. RELATED: Top 10 Medical Device Companies in 2023: Statistics and Trends 1) Pfizer By: Nadia Stec, M.Sc. billion, a 42.74
The Toronto-based company has recently announced positive results from an independent clinical trial which showed that their fluorescence imaging device MolecuLight i :X improved 12-week wound healing of diabetic foot ulcers by 204 percent. What clinical value does this expanded clearance provide?
Augtyro, a tyrosine kinase inhibitor (TKI), is available as oral capsules, each containing 40 mg of repotrectinib. The drug’s efficacy and safety were evaluated in the TRIDENT-1 study, an open-label, single-arm Phase I/II trial, focusing on both TKI-naïve and TKI-pretreated patients. percent (95 percent CI: 46.2 percent, 79.2
The unsealed asbestos experiment files were unearthed in two trials last year pertaining to the baby powder. In another study, Kligman and his colleagues investigated whether the type of containers that the baby powder was stored could have an effect on the skin.
The difference between the two is that Abrysvo is a bivalent vaccine containing equal amounts of stabilized prefusion F antigens from the two major RSV subgroups: RSV A and RSV B. Another difference is that Arexvy contains an adjuvant while Abrysvo does not. billion in 2023, while Abrysvo sales totalled $890 million.
Wegovy’s efficacy and safety for its heart indication were assessed in Novo’s Phase III SELECT cardiovascular outcomes trial that included 17,604 participants who received either Wegovy or placebo, along with standard-of-care treatment like management of blood pressure and cholesterol and counseling about diet and physical activity.
Trial Also Met the Primary Endpoint in Patients With Low Levels of Eosinophils. In the subgroup of patients with baseline eosinophil counts less than 300 cells per microliter, the trial met the primary endpoint with tezepelumab demonstrating a statistically significant and clinically meaningful reduction in AAER. Outside the U.S.,
Firstly, I will list some common combination of drugs, which contain paracetamol, which may be used if standard paracetamol tablets or capsules. Paracetamol: licensed use and limit on the sale . Combination products containing paracetamol. Forms of paracetamol . Analgesic drugs alternative to paracetamol . nerve pains .
Called Phesgo , the new product contains the active substances in Herceptin (trastuzumab) – already facing lower-cost competition in the US and Europe – and Perjeta (pertuzumab), which are both used to treat HER2-positive breast cancers. Phesgo is already available in the US, having been approved by the FDA in the summer. billion ($3.2
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content